PFE earnings
Pfizer (PFE) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
PFE earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | 0.77 | 0.68 | 12.90% | $15.03B |
| Q1 2026 | May 5, 2026 | 0.75 | 0.72 | 3.88% | $14.45B |
| Q4 2025 | Feb 3, 2026 | 0.66 | 0.57 | 16.40% | $17.56B |
| Q3 2025 | Nov 4, 2025 | 0.87 | 0.63 | 37.44% | $16.65B |
| Q2 2025 | Aug 5, 2025 | 0.78 | 0.58 | 34.48% | $14.65B |
| Q1 2025 | Apr 29, 2025 | 0.92 | 0.67 | 38.14% | $13.71B |
| Q4 2024 | Feb 4, 2025 | 0.63 | 0.47 | 33.59% | $17.76B |
| Q3 2024 | Oct 29, 2024 | 1.06 | 0.61 | 72.64% | $17.70B |
| Q2 2024 | Jul 30, 2024 | 0.60 | 0.46 | 31.00% | $13.28B |
| Q1 2024 | May 1, 2024 | 0.82 | 0.52 | 58.91% | $14.88B |
| Q4 2023 | Jan 30, 2024 | 0.10 | -0.19 | 152.63% | $14.25B |
| Q3 2023 | Oct 31, 2023 | -0.17 | -0.32 | 46.88% | $13.49B |
| Aug 1, 2023 | 0.67 | 0.56 | 19.64% | – | |
| May 2, 2023 | 1.23 | 0.98 | 25.51% | – | |
| Jan 31, 2023 | 1.14 | 1.05 | 8.57% | – | |
| Nov 1, 2022 | 1.78 | 1.39 | 28.06% | – | |
| Jul 28, 2022 | 2.04 | 1.78 | 14.61% | – | |
| May 3, 2022 | 1.67 | 1.47 | 13.61% | – | |
| Feb 8, 2022 | 1.08 | 0.85 | 27.06% | – | |
| Nov 2, 2021 | 1.34 | 1.09 | 22.94% | – |
- PFE reports next on Nov 3, 2026, with EPS of 0.73 expected.
- PFE beat EPS estimates in 125 of its last 135 reports.
Updated 2026-11-02 17:53 UTC